Effect of folic acid supplementation on plasma asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase.

被引：0
|
作者：
Title, LM [1 ]
Cummings, PM [1 ]
Giddens, K [1 ]
Nassar, BA [1 ]
机构：
[1] Queen Elizabeth II Hlth Sci Ctr, Halifax, NS, Canada
来源：
CIRCULATION | 2000年 / 102卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
294
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [31] Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure
    Mookerjee, Rajeshwar P.
    Dalton, R. Neil
    Davies, Nathan A.
    Hodges, Stephen J.
    Turner, Charles
    Williams, Roger
    Jalan, Rajiv
    LIVER TRANSPLANTATION, 2007, 13 (03) : 400 - 405
  • [32] Plasma concentrations of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell patients but do not increase further during painful crisis
    Landburg, Precious P.
    Teerlink, Tom
    Muskiet, Frits A. J.
    Duits, Ashley J.
    Schnog, John-John B.
    AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (07) : 577 - 579
  • [33] Asymmetric dimethylarginine, an endogenous NO synthase inhibitor, in human breast milk
    Tsukahara, Hirokazu
    Nagasaka, Hironori
    EARLY HUMAN DEVELOPMENT, 2010, 86 (02) : 69 - 70
  • [34] ENDOGENOUS DIMETHYLARGININE AS AN INHIBITOR OF NITRIC-OXIDE SYNTHESIS
    VALLANCE, P
    LEONE, A
    CALVER, A
    COLLIER, J
    MONCADA, S
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 : S60 - S62
  • [35] The effect of neuropeptides on the expression of nitric oxide synthase.
    Sondhi, R.
    Ee, Y.
    Geen, S. C.
    Shalita, A. R.
    Lee, W.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S1 - S1
  • [36] Induction of insulin resistance in non-diabetic patients with acute heart failure: Association with plasma levels in asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase
    Yasuda, S
    Kanda, M
    Hasegawa, M
    Suzuki, M
    Miyazaki, S
    Harano, Y
    Goto, Y
    CIRCULATION, 2002, 106 (19) : 385 - 386
  • [37] Asymmetric dimethylarginine (ADMA):: a key regulator of nitric oxide synthase
    Böger, RH
    Vallance, P
    Cooke, JP
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (04) : 1 - 3
  • [38] Endogenous nitric oxide synthase (NOS) inhibitor, asymmetrical dimethylarginine (ADMA), in the paraventricular nucleus (PVN) and plasma in renal wrap hypertension
    Northcott, Carrie A.
    Haywood, Joseph R.
    D'Alecy, Louis G.
    Billecke, Scott S.
    FASEB JOURNAL, 2008, 22
  • [39] Asymmetric dimethylarginine, and endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor
    Böger, RH
    JOURNAL OF NUTRITION, 2004, 134 (10): : 2842S - 2847S
  • [40] ASYMMETRIC DIMETHYLARGININE, AN ENDOGENOUS INHIBITOR OF NITRIC OXIDE SYNTHASE, INTERACTS WITH GASTRIC OXIDATIVE METABOLISM AND ENHANCES STRESS-INDUCED GASTRIC LESIONS
    Kwiecien, S.
    Ptak-Belowska, A.
    Krzysiek-Maczka, G.
    Targosz, A.
    Jasnos, K.
    Magierowski, M.
    Szczyrk, U.
    Brzozowski, B.
    Konturek, S. J.
    Konturek, P. C.
    Brzozowski, T.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2012, 63 (05): : 515 - 524
12345